Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Breast Cancer Research and Treatment
|
April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
Maurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
Clinical Colorectal Cancer
|
April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Giorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine
Antonella Perotti, Alberta Locatelli, Cristiana Sessa, et al.
International Journal of Cancer
|
September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy
Valentina Giannini, Samanta Rosati, Arianna Defeudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study
Federico Rojo, Elías Gracias, Nadia Villena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
NPJ Precision Oncology
|
October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Giorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist
|
March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas
Enrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Oncotarget
|
September 30, 2015
KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy
Mirko Marabese, Monica Ganzinelli, Marina C Garassino, et al.
Cancer Discovery
|
May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program
Chiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Breast Cancer Research and Treatment
|
April 30, 2010
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer
Maurizia Mello-Grand, Vijay Singh, Chiara Ghimenti, et al.
Clinical Colorectal Cancer
|
April 15, 2019
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology
Giorgio Corti, Alice Bartolini, Giovanni Crisafulli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2010
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine
Antonella Perotti, Alberta Locatelli, Cristiana Sessa, et al.
International Journal of Cancer
|
September 3, 2020
Radiomics predicts response of individual HER2-amplified colorectal cancer liver metastases in patients treated with HER2-targeted therapy
Valentina Giannini, Samanta Rosati, Arianna Defeudis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
Pharmacodynamic trial of nimotuzumab in unresectable squamous cell carcinoma of the head and neck: a SENDO Foundation study
Federico Rojo, Elías Gracias, Nadia Villena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
NPJ Precision Oncology
|
October 14, 2024
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Giorgio Corti, Kristi Buzo, Enrico Berrino, et al.
The Oncologist
|
March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomas
Enrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Oncotarget
|
September 30, 2015
KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy
Mirko Marabese, Monica Ganzinelli, Marina C Garassino, et al.
Cancer Discovery
|
May 13, 2026
Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program
Chiara Maria Cattaneo, Sharon Scardellato, Gianluca Mauri, et al.
Page
of 9